Study: Alzheimer's drug shows modest success slowing declines in memory, thinking

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

(Image credit: NATIONAL INSTITUTE ON AGING, NIH/AP)

from News : NPR https://ift.tt/XmNq49u